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Hemangiopericytoma (HPC) is a rare perivascular 
tumour classified as a soft-tissue vascular tumour 
featuring the uncontrolled proliferation of pericytic 
cells (1). Showing trend for ubiquitous location, 
soft tissue of lower extremities, pelvic fossa and 
retroperitoneum are the predominant sites of origin. 
Its incidence in the head and neck region has been 
considered approximately less than 20% (2). In this 
area, the majority of the reported cases are in the 
nasal cavity and paranasal sinuses, nasopharynx, 
jawbones, orbit and scalp; other areas involved have 
included parotid and submandibular gland, larynx, 
parapharyngeal space, sinus tract and meninges, 
trachea, middle ear, oral cavity and thyroid gland (1).
A review of the medical literature on tumours 
occupying the infratemporal fossa reveals that primary 
HPCs of this anatomical space are exceedingly rare, 
secondary involvement due to direct extension from 
adjacent sites being more commonly found (3). To 
the best of our knowledge, only nine previous cases 
of primary HPCs involving the infratemporal fossa 
have been reported up until the end of 2018 (Table 
I) (2). We report herein an additional case of HPC 
arising in the infratemporal fossa, describing the 
gross and microscopic features of this lesion, as well 
as clinical presentation, management and outcomes. 
In September 2001, a 23-year-old woman was 
referred to the Oral and Maxillofacial Surgery 
Department for evaluation and treatment of a left-
sided facial swelling. The mass had been growing 
slowly over a 1-year period with no history of 
trauma, fever, pain, paraesthesia or dysphagia. The 
patient gave informed consent to report her case. 
On examination, a large well-demarcated, smooth-
lobular, elastic-hard, compressible, immobile mass 
was found on the left facial region. The bulging was 
not adherent to the skin and there was no discoloration, 
bruit, thrill or pulsation. The examination of the 
neck did not reveal lymphadenopathies. The patient 
showed a full range of mandibular motion and 
normal salivary flow from the major duct of the 
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the fifth postoperative day. After 18 years of clinic-
instrumental recall examinations there is no evidence 
of local recurrence or distant metastases.
DISCUSSION
Since its descriptions in 1942 by Stout and Murray, 
hemangiopericytoma has evoked controversy mainly 
because of its uncertain pathological entity. Several 
articles have questioned whether it is a histopathologic 
pattern or a clinicopathologic entity, a diagnosis of 
exclusion, a wastebasket diagnosis or a dying breed 
(4-6). Basically, HPC is characterized as benign or 
malignant, round to spindle-shaped cell tumour with 
numerous “staghorn” branching vascular channels. 
First of all, the histologic, immunohistochemical, 
and ultrastructural features of HPC seem to be rather 
unspecific. The HPC-like vascular pattern can be 
present in many neoplasms such as synovial sarcoma, 
mesenchymal chondrosarcomas, benign and 
malignant fibrous histiocytoma, malignant peripheral 
nerve sheath tumours, solitary fibrous tumours, 
malignant mesotheliomas, leiomyosarcomas, 
thymomas, sarcomatous carcinomas, endometrial 
stromal sarcomas (7). Secondly, there is a clearly 
noticeable variation in the clinical course, and 
histologic grading does not necessarily correlate 
with biological behaviour. According to the World 
Health Organization, HCP is graded as grade II 
and III, depending on the mitotic rate (› 5 mitoses 
per 10 high-power fields), high cellularity, nuclear 
pleomorphism, haemorrhage and necrosis. Thirdly, 
there is a lack of understanding regarding the nature 
and function of the pericytes. Originally identified 
by Rouget in 1873 and subsequently described 
by Zimmermann in 1923, these are cells with 
modified, smooth muscle characteristic that are 
highly arborized and arranged alongside capillary 
vessels where they have a contractile capability and 
are responsible for vessel calibre regulation, and 
modulating both flux and permeability. However, 
other authors have postulated that pericytes represent 
versatile precursors of other mesenchymal cells, 
such as fibroblasts (8). There is no general agreement 
as to the aetiology of this neoplasm, although HPC 
has been linked to infection by an oncogenic virus, 
parotid gland. The intraoral hard and soft tissues 
were completely normal, and the caudal aspect of the 
mass was palpated in the posterior maxillary region 
where a partial obliteration of the left gingiva-buccal 
sulcus was observed. Fine needle aspiration obtained 
only blood. A careful intraoral punch biopsy attempt 
was hampered by copious bleeding, which required 
haemostatic package and suture. The subsequent 
histology was inconclusive. A post-contrast 
computed tomographic scan confirmed an enhanced 
soft-tissue mass extending from the left infratemporal 
fossa to the homolateral mandibular ramus with 
no evidence of bony destruction or of intracranial 
extension. Magnetic resonance imaging (MRI) with 
gadolinium enhancement showed a large lobular-
shaped mass that was embedding exteriorly the inner 
surface of the zygomatic arch and of the masseter 
muscle and posteriorly the temporal muscle and 
the lateral surface of the external pterygoid muscle 
(Fig. 1). In all its extension the mass showed clear 
contouring without signs of surrounding anatomical 
invasion. The tumour was highly perfused. This was 
confirmed by angiography (Fig. 2). 
The supplying vessel originating from the 
left maxillary artery was selectively embolized. 
Thereafter, the tumour was surgically resected via 
a transfacial route by means of Weber-Ferguson 
approach. Macroscopically, the specimen consisted of 
a regularly pseudo capsuled lobular-mass measuring 
6.5 x 5 x 2.5 cm in its greatest dimensions (Fig. 3). 
On cross surface, a solid portion was observed of the 
lesion intermingled with cystic features with gray-
brown haemorrhagic areas and a jelly-like consistency. 
Sections from formalin-fixed tissue stained with 
haematoxylin and eosin exhibited round and spindle-
shaped tumour cells arranged in nest patterns with ill-
defined borders and round-to-oval nuclei surrounding 
the endothelial-lined vascular channels (Fig. 4). The 
anastomosing vessel ranged from capillary to large 
sinusoidal spaces, revealing a multiple staghorn 
pattern. Cellular pleomorphism was minimal and 
more than two mitotic figures per 10 high-powered 
fields were present. The definitive histopathological 
diagnosis was consistent with HPC.
The postoperative course was entirely uneventful, 
and the patient was discharged from the hospital on 
G.A. PACINO ET AL.
PRO
OF
121Journal of Biological Regulators & Homeostatic Agents
and can underestimate the full extent of the mass. 
MR imaging findings, albeit not specific, may reveal 
a well to fairly circumscribed lobular soft tissue mass 
with intermediate signal intensity on T1-weighted 
sequences, mild hyper-intensity on T2-weighted 
sequences and a marked gadolinium enhancement. 
A feeder vascular pedicle with radial branching 
wrapping a well-demarcated tumour stain, such as 
observed in our case, is reported as a characteristic 
angiographic finding in HPC, therefore it is not of 
unequivocal value in all cases.
The large number of possible diagnoses of 
swelling of the infratemporal fossa and aspecificity 
of the clinic-instrumental presentation make a 
suspect diagnosis extremely difficult and only a 
detailed histopathological assessment can lead to the 
correct definitive diagnosis (11). 
A review of the ten reported cases of infratemporal 
fossa primary HPC (Table I), including our case 
described herein, revealed a slight sex predominance 
(6 females, 4 males) with a mean age of 39 years. 
The most common clinical complaint was a 
palpable painless mass (9/10). Radical surgery was 
the treatment of choice (9/10). Complete surgical 
resection is considered the mainstay of treatment 
for localized and resectable tumours, giving an 
approximately overall cure rate of 50% at all sites. 
Preoperative embolization has been suggested as 
traumatic factors, prolonged steroid therapy and 
hormonal imbalance. Recent biomolecular research 
suggests that endothelial and non-endothelial 
sources of angiogenetic factors seem to regulate 
pericyte recruitment and influence vascular pattern 
formation during the pathogenetic development of 
HPC (9, 10). 
Enzinger and Smith have allocated this 
uncommon tumour to two groups: an adult type and 
a congenital or infantile type. In elderly patients, the 
tumour seems to be deeply sited, located in muscle 
tissue and showing more frequently a malignant 
course, whereas the congenital or infantile forms 
are almost invariably superficial in site, and appear 
to behave in a benign fashion. In the head and neck 
area, this neoplasm presents in a rather unspecific 
way; often, symptoms are directly related to the 
anatomic location of the neoplasm. 
Computed tomography scan is superior to most 
studies, but it often fails to define planes, may not 
always clearly indicate the vascularity of the lesion, 
Fig. 1. Sagittal T1-weighted MR image depicts a large, 
well demarcated lobular soft-tissue mass extending from 
the left infratemporal fossa to the mandibular ramus. On 
this sequence the lesion shows an inhomogeneous matrix 
with prominent internal flow void.
Fig. 2. Common carotid angiography demonstrating 
a highly vascular lesion with dense staining and 






an adjunct for decreasing tumour vascularity and 
size in order to obtain a successful resection. Of 
the ten reported cases, only six patients received 
perioperative embolization, and virtually no bleeding 
was encountered during tumour resection, while the 
remaining HPCs were amenable to surgical resection 
without embolization.
The usefulness of adjuvant radiant therapy has 
not been fully supported in the literature, although 
several studies suggest that radiotherapy can be 
used in case of incomplete resection, unresectable or 
recurrent disease. Chemotherapy can be useful for 
preoperative tumour reduction as a postoperative 
adjunct for tumour metastases and for palliative 
purposes. Positive responses have been reported 
for Adriamycin alone or in combination with 
cyclophosphamide, vincristine, methotrexate or 
actinomycin D, although several authors still 
consider HPC chemotherapy-resistant. In our review, 
one patient with metastatic disease died within a 
short period of receiving chemotherapy.
In spite of light, scanning and transmission electron 
microscopy as well as immunohistochemical and 
electron microscopical studies, no definite histological 
criteria indicative of benign or malignant HPCs could 
be established. The relapses and/or occurrence of 
metastases even after many years, as observed in our 
review series, makes the existence of benign variant 
once again questionable. It appears appropriate to 
Fig. 3. Surgical specimen measuring 6.5 x 5 x 2.5 cm in its 
greatest dimensions.
Fig. 4. Haematoxylin and Eosin section showing marked 
proliferation of round to spindle-shaped cells with 
atypical cellularity around branching vessels (Original 
magnification X 150)
Fig. 2. Common carotid angiography demonstrating a highly vascular lesion with dense staining 
and displacement of major vessel. 
 
Fig. 3. Surgical specimen measuring 6.5 x 5 x 2.5 cm in its greatest dimensions. 
 
Fig. 4. Haematoxylin and Eosin section showing marked proliferation of round to spindle-shaped 









    
N.D: not defined; NED: no evidence of disease; HPF: High-power fields. 
* This patient had a history of three prior resection of HPC of the infratemporal fossa 










1 Philippou et al.  (1992) M/27 Painless facial swelling Embolization-Surgery-
Radiotherapy 
4 cm 8 mitosis x 10 HPF N.D. NED 
2 Philippou et al.  (1992) F/53 Slow growing mass Surgery 8 cm Sparse 16 years Recurrent multiple 
relapses treated with 
radio-chemotherapy; 
death for liver metastatic 
disease 
3 Piral et al.  (1995) F/24 Painless facial swelling Embolization-Surgery 5 cm Sparse 3 years NED 
4 Hemar et al.  (1996) M/61 Otitis, Epistaxis* Embolization-Surgery N.D. N.D. 15 months NED 
5 Kanazawa et al.  (2001) M/42 Painless facial swelling, facial 
palsy 
Embolization-Surgery 2.7 x 2.5 cm Absent 5 years NED 
6 Bianchi et al.  (2002) F/72 Painless facial mass Embolization-Surgery 3.2 x 4.2 cm Sparse 3 years NED 
7 Boulaich et al.  (2003) M/16 Oropharingeal mass, 
dysphagia 
Surgery N.D. Sparse 10 years NED 
8 Boulaich et al.  (2003) F/60 Painless facial swelling Surgery N.D. Absent 3 years Death for untreatable 
local relaps and bone 
metastatic disease 
9 Shetty et al.  (2007) F/12 Painless facial mass, visual 
disturbance 
N.D.** 10 x 10 cm Sparse N.D. N.D. 
10 Pacino et al.  2019 F/23 Painless facial mass, intraoral 
bulging 
Embolization-Surgery 6.5 x 5 cm 2 mitosis x 10 HPF 11 years NED 
Table I. Previous cases of primary HPCs involving the infratemporal fossa reported in the literature.
N.D: not defined; NED: no evidence of disease; HPF: High-power fields. * This patient had a history of three prior 
resection of HPC of the infratemporal fossa. ** In this patient only, a biopsy was performed
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5. Spinato G, Cazzato G, Ferlito S, et al. Therapeutical 
innovations and medical responsibility: What’s new 
in otolaryngology. Acta Medica Mediterranea 2018; 
34:307-12. doi:10.19193/0393-6384_2018_2_49
6. Sutbeyaz Y, Selimoglu E, Karasen R, Ciftcioglu A, 
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1995; 109:977-79. doi:10.1017/S0022215100131809
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doi:10.26355/eurrev_201905_17912
11. Shetty SR, Chatra L, Shenai KP. Orofacial 
haemangiopericytoma--a rare case. Dentomaxillofac 
Radiol 2007; 36(7):437-40. doi:10.1259/
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12. Ciofalo A, Gulotta G, Iannella G et al. Giant Cell Arteritis 
(GCA): Pathogenesis, Clinical Aspects and Treatment 
Approaches. Currt Rheumatol Rev 2019; 15(4):259-68. 
doi:10.2174/1573397115666190227194014
consider all HPCs as potentially malignant. The 
clinical course alone determines whether or not the 
tumour is clustered benign or malignant.
HPC of the head and neck are believed to behave 
more favourably compared with their counterparts 
in other anatomic sites. No apparent explanation 
for this less malignant behaviour is evident, and the 
reported recurrence rate in literature ranges from 40-
50%. Data from our review series seem to support 
the aforementioned contention with a recurrence 
rate of 22%. Overall, metastases occur in 18-50% of 
patients, mostly to the lung, liver and bone. Given 
the rarity and lack of unequivocal opinions on the 
management of the pathology, it is very important to 
establish specific guidelines for the correct treatment 
of the same (12).
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